The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients

Clinical trial NCT01200550 · COMPLETED

Trial details

NCT number: NCT01200550
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Gastroesophageal Reflux Disease

Start date: 2010-09-01
Primary completion: 2011-09-01
Enrollment: 1233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.